Daily Peptide Briefing

Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial.

BMJ open

One receptor, two opposite approaches: efficacy and tolerability of GIPR agonism and antagonism in obesity pharmacotherapy.

Appetite

Effects of tirzepatide therapy on body weight and body composition in adults with overweight and obesity.

Frontiers in endocrinology

Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?

Journal of the Endocrine Society

Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report.

Clinical case reports

Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis.

Endocrinology, diabetes & metabolism

AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models.

Nature communications

Therapeutic Potential of Incretin-Based Therapies for Alcohol Use Disorder - A narrative review of available clinical evidence.

Biological psychiatry

🚨 $HIMS CHIEF MEDICAL OFFICER, ANANT VINJAMOORI, AT THE FDA PEPTIDES MEETING: "My company [Hims & Hers] intends to offer peptide therapy if allowed. We intend to do so with guardrails because we think that is in the best interest of patients." "We would, in fact, benefit https://t.co/bR3aUJC27D https://t.co/KyMuYsXyDL

I've tested over 100 compounds since 2017 (peptides, shrooms, TRT, nicotine, etc.) to improve my health, performance, and focus. A short list of the ones that made the greatest impact: 1) GLP-1s (the heaviest hitters I've ever used) - Retatrutide - Tirzepatide - Semaglutide

The most popular peptides in the research and biohacking world right now: → BPC-157 (healing) → TB-500 (recovery) → Retatrutide (fat loss) → Semaglutide & Tirzepatide (fat loss) → CJC-1295 + Ipamorelin (growth hormone) → Semax & Selank (focus)

our full reptides peptide tier list: S: - tirzepatide - semaglutide - retatrutide - liraglutide - orforglipron - tesamorelin - hgh - hcg - ghk-cu A: - ss-31 - pt-141 - survodutide - mazdutide - sermorelin - bpc-157 - tb-500 - cjc+ipa - cjc-1295 - ipamorelin - bpc+tb -

HANGİ PEPTİT HANGİ AMAÇLA KULLANILIYOR? Retatrutide — obezite ve metabolik hastalık araştırmaları (GLP-1/GIP/Glukagon agonisti) Tirzepatide — kilo kaybı ve tip 2 diyabet araştırmaları Semaglutide — iştah kontrolü ve glukoz metabolizması Cagrilintide — iştah baskılama ve kilo https://t.co/xIQdvyfWVt

The next 2 weeks could be the biggest stretch of 2026 for $HIMS. There are 2 major catalysts investors should be watching and understand. 1) FDA Compounded Peptide Advisory Meeting First, this is not the FDA’s final decision. Here’s how it works: - Independent experts https://t.co/JDEyZ1iIkZ

Semaglutide and tirzepatide are often discussed as if they were interchangeable. They are not. Semaglutide targets the GLP-1 receptor. Tirzepatide targets both GIP and GLP-1 receptors, creating a different pharmacologic profile.

🚨 BPC-157 and KPV just received favorable PCAC votes for the 503A Bulk Drug Substances List - 2 of 7 peptides now recommended ✅ Today on July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) delivered important non-binding recommendations during day one of https://t.co/iNlQaFx9lH